Phase 3 Trial of BI 695502 Plus Chemotherapy Versus Bevacizumab Reference Product Plus Chemotherapy in Patients With Advanced Nonsquamous NSCLC
Autor: | Kim, Edward S., Balser, Sigrid, Rohr, Klaus B., Lohmann, Ragna, Liedert, Bernd, Schliephake, Dorothee |
---|---|
Zdroj: | In JTO Clinical and Research Reports January 2022 3(1) |
Databáze: | ScienceDirect |
Externí odkaz: |